MDS to Present at UBS Global Life Sciences Conference and CIBC World Markets Institutional Investor Conference
20 September 2007 - 2:00PM
PR Newswire (US)
TORONTO, Sept. 20 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;
NYSE: MDZ), a leading provider of products and services to the
global life sciences markets, announced today that Stephen P.
DeFalco, President and Chief Executive Officer, will be presenting
at the UBS Global Life Sciences Conference in New York on Thursday,
September 27th, at 9:30 am Eastern Standard Time. The Company also
announced today that Douglas Prince, Executive Vice-President
Finance and Chief Financial Officer, will be presenting at the CIBC
World Markets 6th Annual Eastern Institutional Investor Conference
in Mont Tremblant, Quebec on Thursday, September 27th, at 10:00 am
Eastern Standard Time. Interested parties may access the live
webcast of each conference by visiting the "Upcoming Events"
section of the MDS home page at http://www.mdsinc.com/ and clicking
on the conference link. An audio archive and the presentation
slides will also be available after each event on the "Webcasts
& Presentations" page in our "For Investors" section of the MDS
website. MDS Inc. is a global life sciences company that provides
market-leading products and services that our customers need for
the development of drugs and the diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
6,200 highly skilled people in 28 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Investors: Sharon Mathers,
Senior Vice-President, Investor Relations and External
Communications, (416) 675-6777 ext. 34721,
Copyright